BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11927549)

  • 1. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.
    Kang SJ; Cresswell P
    EMBO J; 2002 Apr; 21(7):1650-60. PubMed ID: 11927549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments.
    Anderson HA; Bergstralh DT; Kawamura T; Blauvelt A; Roche PA
    J Immunol; 1999 Nov; 163(10):5435-43. PubMed ID: 10553069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments.
    Anderson HA; Roche PA
    J Immunol; 1998 May; 160(10):4850-8. PubMed ID: 9590232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d.
    Chiu YH; Park SH; Benlagha K; Forestier C; Jayawardena-Wolf J; Savage PB; Teyton L; Bendelac A
    Nat Immunol; 2002 Jan; 3(1):55-60. PubMed ID: 11731798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
    Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
    Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In the absence of major histocompatibility complex class II molecules, invariant chain is translocated to late endocytic compartments by autophagy.
    Chervonsky A; Sant AJ
    Eur J Immunol; 1995 Apr; 25(4):911-8. PubMed ID: 7737293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1 and MHC II find different means to the same end.
    Sullivan BA; Nagarajan NA; Kronenberg M
    Trends Immunol; 2005 May; 26(5):282-8. PubMed ID: 15866242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
    Swier K; Miller J
    J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice.
    Sevilla LM; Richter SS; Miller J
    Cell Immunol; 2001 Jun; 210(2):143-53. PubMed ID: 11520080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
    Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
    J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling.
    Nijenhuis M; Calafat J; Kuijpers KC; Janssen H; de Haas M; Nordeng TW; Bakke O; Neefjes JJ
    Eur J Immunol; 1994 Apr; 24(4):873-83. PubMed ID: 8149958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late events in the intracellular sorting of major histocompatibility complex class II molecules are regulated by the 80-82 segment of the class II beta chain.
    Tan LJ; Ceman S; Chervonsky A; Rodriguez-Paris J; Steck TL; Sant AJ
    Eur J Immunol; 1997 Jun; 27(6):1479-88. PubMed ID: 9209501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
    Khalil H; Brunet A; Thibodeau J
    J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains.
    Théry C; Brachet V; Regnault A; Rescigno M; Ricciardi-Castagnoli P; Bonnerot C; Amigorena S
    J Immunol; 1998 Sep; 161(5):2106-13. PubMed ID: 9725201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular pathway for the generation of functional MHC class II peptide complexes in immature human dendritic cells.
    Saudrais C; Spehner D; de la Salle H; Bohbot A; Cazenave JP; Goud B; Hanau D; Salamero J
    J Immunol; 1998 Mar; 160(6):2597-607. PubMed ID: 9510157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
    Henne C; Schwenk F; Koch N; Möller P
    Immunology; 1995 Feb; 84(2):177-82. PubMed ID: 7750992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of major histocompatibility complex class II compartments in cortical thymic epithelial cells.
    Arudchelvan Y; Nishimura Y; Tokuda N; Sawada T; Ueyama Y; Fukumoto T
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Sep; 274(1):798-806. PubMed ID: 12923890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The invariant chain induces compact forms of class II molecules localized in late endosomal compartments.
    Humbert M; Raposo G; Cosson P; Reggio H; Davoust J; Salamero J
    Eur J Immunol; 1993 Dec; 23(12):3158-66. PubMed ID: 8258330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical tyrosine residue in the cytoplasmic tail is important for CD1d internalization but not for its basolateral sorting in MDCK cells.
    Rodionov DG; Nordeng TW; Pedersen K; Balk SP; Bakke O
    J Immunol; 1999 Feb; 162(3):1488-95. PubMed ID: 9973405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.